Alexandre de Araújo

Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma

Federico Piñero, Manuel Mendizábal, Ezequiel Ridruejo et al. · Liver International · 2019 · 89 citations · Full text

Medicine, Oncology, Pharmacology +15

Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents

Manuel Mendizábal, Federico Piñero, Ezequiel Ridruejo et al. · Clinical Gastroenterology and Hepatology · 2020 · 72 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Oral l‐ornithine‐l‐aspartate in minimal hepatic encephalopathy: A randomized, double‐blind, placebo‐controlled trial

Mário Reis Álvares‐da‐Silva, Alexandre de Araújo, João Reinhardt Vicenzi et al. · Hepatology Research · 2013 · 59 citations

Medicine, Pharmacology, Pharmacotherapy +16

Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil

Hugo Cheinquer, Fernando Herz Wolff, Alexandre de Araújo et al. · Annals of Hepatology · 2017 · 55 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Pre-transplant ALBI Grade 3 Is Associated with Increased Mortality After Liver Transplantation

Nicole Bernardi, Márcio F. Chedid, Tomaz J. M. Grezzana‐Filho et al. · Digestive Diseases and Sciences · 2019 · 29 citations · Full text

Medicine, Surgery, Hepatology +13